Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Barriers to participating in genetic counseling and BRCA testing during primary treatment for breast cancer.

Genetics in medicine : official journal of the American College of Medical Genetics - 1 Nov 2007

Schlich-Bakker Kathryn J, ten Kroode Herman F J, Wárlám-Rodenhuis Carla C, van den Bout Jan, Ausems Margreet G E M

Abstract excerpt

PURPOSE: Little is known about reasons why eligible breast cancer patients decline BRCA mutation testing. They may withdraw at different stages during genetic counseling for different reasons. We prospectively studied perceived benefits and barriers to genetic counseling and BRCA testing in 102 newly diagnosed breast cancer patients approached for genetic counseling at the start of radiotherapy. METHODS: Patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Attitude to Health
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Counseling

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Genetic Testing

Share to Mutation

Share to Surveys and Questionnaires

Source

Identifiers

PMID: 18007146
DOI: 10.1097/gim.0b013e318159a318

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Barriers to participating in genetic counseling and BRCA testing during primary treatment for breast cancer.PMID 18007146Read ↗

Factors Associated with an Individual's Decision to Withdraw from Genetic Testing for Breast And Ovarian Cancer Susceptibility: Implications for CounselingSemantic proximity Read ↗

Non-uptake of predictive genetic testing for BRCA1/2 among relatives of known carriers: attributes, cancer worry, and barriers to testing in a multicenter clinical cohort.Semantic proximity Read ↗

BRCA1/2 mutation testing in breast cancer patients: a prospective study of the long-term psychological impact of approach during adjuvant radiotherapy.Semantic proximity Read ↗

Distress in unaffected individuals who decline, delay or remain ineligible for genetic testing for hereditary diseases: a systematic review.Semantic proximity Read ↗

Patients' willingness to reconsider cancer genetic testing after initially declining: Mention it againSemantic proximity Read ↗

What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing.Semantic proximity Read ↗

High Satisfaction and Low Distress in Breast Cancer Patients One Year after BRCA-Mutation Testing without Prior Face-to-Face Genetic Counseling.Semantic proximity Read ↗

Choosing not to undergo predictive genetic testing for hereditary colorectal cancer syndromes: expanding our understanding of decliners and declining.Semantic proximity Read ↗

Attitudes and distress levels in women at risk to carry a BRCA1/BRCA2 gene mutation who decline genetic testing.Semantic proximity Read ↗

Why do women not return family history forms when referred to breast cancer genetics services? A mixed-method study.Semantic proximity Read ↗

Implementation and outcomes of telephone disclosure of clinical BRCA1/2 test results.Semantic proximity Read ↗

"Maybe they have found something new" participants' views on returning cohort psychosocial survey results.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.